Medtronic’s Diabetes Management Business MiniMed Files for IPO

MiniMed Group Inc., a diabetes management firm that will be separated from health care giant Medtronic Plc, filed for an initial public offering, disclosing growing revenue and a shrinking net loss. The Northridge, California-based company had a net loss of $21 million on revenue of $1.5 billion for the six months ended October 24, compared with a net loss of $23 million on revenue of $1.3 billion in the corresponding period a year earlier, according to its filing Friday with the US Securities and Exchang ...